1.Ozer N, Tangurek B, Tartan Z, Ozer S, Terzi S, Ozay B, Ciloğlu F, Asilturk R, Yilmaz H, Cam N. “Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention,” Heart Vessels, 2008 Mar;23(2):75-82. Apr 4 Epub (2008).
2.Ozer N, Cam N, Tangurek B, Ozer S, Uyarel H, Oz D, Guney MR, Ciloglu F.
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient
characteristics upon warfarin dose requirements in an adult Turkish
population. Heart. Vessels (2010)
3.Özer N, Demirci D, Tipi F, Özer S, Tartan Z, Uyarel H, Çam N, “Role of Hs CRP in Right Ventricle Myocardial Infarction," Journal of MN-Cardiology, 15 (3)
4.Özer N, Çam N, Uyarel H, Püşüroğlu H, Bolat İ, Tartan Z, Özer S, Öztürk R, “The Relationship Between Soluble CD40 Ligand and Myeloperoxidase Level Measured During the Admission and ST-Segment Regression Following Successful Primary Percutaneous Coronary Intervention,’’ MN-Cardiology Journal, (Accepted for publication) (2008).
5.Emre A, Yakut Y, Özer S, Gürsürer M, Yazıcıoğlu MV, Yardı ÖF, Ünal D, Ersek B, “The Relationship Between Endogenous Sex Hormone Levels and Severe Ischemia in Postmenopausal Women with Chronic Coronary Artery Disease”, XV. National Congress of Cardiology, 11-14 October, Antalya, Turkey, (2000).
6.Özer N, Demirci D, Tipi F, Özer S, Elibol A, Püşüroğlu H, Belen B, Öztürk R, Uyarel H, Tartan Z, Çam N, “The Effect of CYP2C9 and VCORC1 Genetic Polymorphism and Patient Characteristics on Warfarin Dose Requirement in Adult Turkish Population”,
XXIV. National Cardiology Congress, 24-27 October, Istanbul, Turkey, (2008).
7.Özer N, Tipi F, Demirci D, Özer S, Tartan Z, Öztürk R, Elibol A, Püşüroğlu H, Belen E, Uyarel H, Çam N, “Effects of Stents with Drug Release on Systemic Inflammatory Response in Patients with Unstable Angina Pectoris Who Underwent Percutaneous Coronary Artery Intervention.”, XXIV. National Cardiology Congress, 24-27 October, Istanbul, Turkey, (2008).